Newton, MA, United States of America

Monica Bertagnolli

USPTO Granted Patents = 3 

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2013-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Monica Bertagnolli: Innovator in Cancer Research**

Introduction

Monica Bertagnolli, located in Newton, MA, is an acclaimed inventor specializing in advancements in cancer treatment. With three patents to her name, she has made significant contributions to the field of oncology, particularly in the development of innovative therapies aimed at combatting cancer.

Latest Patents

Bertagnolli's latest patents include groundbreaking work on humanized and affinity-matured anti-CEACAM1 antibodies, which provide recombinant antibodies and antigen-binding fragments useful for targeting and inhibiting carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1). Her inventive methods utilize these antibodies for reducing T-cell tolerance, aiming to enhance cancer treatment efficacy. Another notable patent focuses on 15-PGDH in colon cancer, presenting methods to decrease resistance to chemopreventive properties of non-steroidal anti-inflammatory agents, such as celecoxib. This work includes identifying compounds that can upregulate or reactivate 15-PGDH, thus facilitating better treatment outcomes for patients at risk of colon cancer.

Career Highlights

Monica Bertagnolli has built a distinguished career through her work at prominent institutions, including The Brigham and Women's Hospital and Case Western Reserve University. Her research has been pivotal in advancing methods for cancer prevention and treatment, thereby influencing clinical practices in oncology.

Collaborations

Throughout her career, Bertagnolli has collaborated with esteemed colleagues such as Sanford D Markowitz and Richard S Blumberg. These collaborations have further enriched her research and innovation in cancer therapies, fostering a multidisciplinary approach to tackling complex medical challenges.

Conclusion

Monica Bertagnolli's innovative contributions to cancer research underscore her role as a leading inventor in the medical field. With her advanced methodologies and collaborative spirit, she continues to pave the way for new treatments that hold promise for patients battling cancer. Her work not only enhances scientific understanding but also has the potential to translate into life-saving therapies for those in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…